Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026. The company’s urology, acute care, and OEM businesses will be grouped under ...

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported disappointing fourth-quarter results, with revenue missing expectations by a ...

Teleflex's management announced a significant acquisition and business split, but the market reacted negatively, dropping the shares over 20%. Fourth quarter earnings and 2025 guidance show weak ...

Teleflex plans to split into two companies by mid-2026, with RemainCo focusing on high-growth hospital markets and NewCo on urology and OEM. Teleflex will acquire Biotronik's Vascular Intervention ...

2024 Financial Performance For Q4, Teleflex posted revenues of $795.4 million, reflecting a 2.8% increase compared to the ...

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021. TFX stock was trading at around $246 in ...

In the last three months, 5 analysts have published ratings on Teleflex (NYSE:TFX), offering a diverse range of perspectives from bullish to bearish. The following table provides a quick overview ...

Aug 1 (Reuters) - Surgical equipment maker Teleflex (TFX.N), opens new tab raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals ...